{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T23:35:20Z","timestamp":1794353720293,"version":"4.9.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82202828"],"award-info":[{"award-number":["82202828"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82104089"],"award-info":[{"award-number":["82104089"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2025,4,14]]},"DOI":"10.1038\/s41388-025-03331-1","type":"journal-article","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T04:58:51Z","timestamp":1741841931000},"page":"909-926","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["CBX2 as a therapeutic target in colorectal cancer: insights into the altered chromatin accessibility via RUNX1-CBX2-MAP4K1 axis"],"prefix":"10.1038","volume":"44","author":[{"given":"Bangting","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shijie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumeng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqing","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiankun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunming","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3132-8511","authenticated-orcid":false,"given":"Li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,13]]},"reference":[{"key":"3331_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"3331_CR2","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1053\/j.gastro.2020.02.068","volume":"159","author":"A Melina","year":"2020","unstructured":"Melina A, Christian CA, Rachel EN, Jerome V, Edward LG, Katherine AM, et al. Global burden of 5 major types of gastrointestinal cancer. Gastroenterology. 2020;159:335\u201349.e15.","journal-title":"Gastroenterology"},{"key":"3331_CR3","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.3390\/cancers16081530","volume":"16","author":"R Gholamreza","year":"2024","unstructured":"Gholamreza R, Fatemeh G-K, Reza M. Colorectal cancer: epidemiology, risk factors, and prevention. Cancers. 2024;16:1530.","journal-title":"Cancers"},{"key":"3331_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-47204-9","volume":"15","author":"X Junyi","year":"2024","unstructured":"Junyi X, Dongying G, Shuwei L, Sangni Q, Yifei C, Wei S, et al. Integration of pathologic characteristics, genetic risk and lifestyle exposure for colorectal cancer survival assessment. Nat Commun. 2024;15:3042.","journal-title":"Nat Commun"},{"key":"3331_CR5","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1038\/s41416-024-02696-6","volume":"130","author":"AH Ree","year":"2024","unstructured":"Ree AH, \u0160altyt\u0117 Benth J, Hamre HM, Kersten C, Hofsli E, Guren MG, et al. First-line oxaliplatin-based chemotherapy and nivolumab for metastatic microsatellite-stable colorectal cancer-the randomised METIMMOX trial. Br J Cancer. 2024;130:1921\u20138.","journal-title":"Br J Cancer"},{"key":"3331_CR6","doi-asserted-by":"crossref","unstructured":"Marwan F, Chongkai W, Jaideep S, Jian Y, Colt E, Xiaochen L. Immunotherapy response in microsatellite stable metastatic colorectal cancer is influenced by site of metastases. Eur J Cancer. 2023;196:113437.","DOI":"10.1016\/j.ejca.2023.113437"},{"key":"3331_CR7","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1158\/2159-8290.CD-24-0217","volume":"14","author":"Y Rona","year":"2024","unstructured":"Rona Y, Nataliya VU, Meredith SP, Tanios SB-S, Minal B, Joel S, et al. Efficacy and safety of adagrasib plus cetuximab in patients with KRASG12C-mutated metastatic colorectal cancer. Cancer Discov. 2024;14:982\u201393.","journal-title":"Cancer Discov"},{"key":"3331_CR8","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1080\/14728222.2023.2218614","volume":"27","author":"WB Lindsay","year":"2023","unstructured":"Lindsay WB, Donald SB, Vu TN, Philip R, Tomomi MY, Elizabeth RW, et al. Novel chromobox 2 inhibitory peptide decreases tumor progression. Expert Opin Ther Targets. 2023;27:361\u201371.","journal-title":"Expert Opin Ther Targets"},{"key":"3331_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01603-y","volume":"21","author":"DG Nunzio","year":"2022","unstructured":"Nunzio DG, Antonella DC, Ning Qing L, Lidio C, Carmela DA, Guglielmo B, et al. CBX2 shapes chromatin accessibility promoting AML via p38 MAPK signaling pathway. Mol Cancer. 2022;21:125.","journal-title":"Mol Cancer"},{"key":"3331_CR10","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1016\/j.molcel.2023.03.018","volume":"83","author":"E Glancy","year":"2023","unstructured":"Glancy E, Wang C, Tuck E, Healy E, Amato S, Neikes HK, et al. PRC2.1- and PRC2.2-specific accessory proteins drive recruitment of different forms of canonical PRC1. Mol Cell. 2023;83:1393\u2013411.e7.","journal-title":"Mol Cell"},{"key":"3331_CR11","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/nsmb.3248","volume":"23","author":"LK Susan","year":"2016","unstructured":"Susan LK, Matthew MM, Baymaz HI, Lisa VV, Ino DK, Alexandra S, et al. The dynamic interactome and genomic targets of Polycomb complexes during stem-cell differentiation. Nat Struct Mol Biol. 2016;23:682\u201390.","journal-title":"Nat Struct Mol Biol"},{"key":"3331_CR12","doi-asserted-by":"publisher","first-page":"3030","DOI":"10.1016\/j.celrep.2016.03.032","volume":"14","author":"Z Wunderlich","year":"2016","unstructured":"Wunderlich Z, Bragdon MDJ, Vincent BJ, White JA, Estrada J, DePace AH. Non-canonical PRC1.1 targets active genes independent of H3K27me3 and is essential for leukemogenesis. Cell Rep. 2016;14:3030.","journal-title":"Cell Rep"},{"key":"3331_CR13","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/nrc1991","volume":"6","author":"S Anke","year":"2006","unstructured":"Anke S, Maarten VL. Polycomb silencers control cell fate, development and cancer. Nat Rev Cancer. 2006;6:846\u201356.","journal-title":"Nat Rev Cancer"},{"key":"3331_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-021-02147-9","volume":"21","author":"Z He","year":"2021","unstructured":"He Z, Yongfu X, Zuoliang L, Songlin H, Tong Z. Expression and prognostic significance of CBX2 in colorectal cancer: database mining for CBX family members in malignancies and vitro analyses. Cancer Cell Int. 2021;21:449.","journal-title":"Cancer Cell Int"},{"key":"3331_CR15","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.7150\/jca.92633","volume":"15","author":"S Rui","year":"2024","unstructured":"Rui S, Xucan T, Shixin C, Xu W, Yizhong J, Zhenglin W, et al. CBX2 deletion suppresses growth and metastasis of colorectal cancer by Mettl3-p38\/ERK MAPK signalling pathway. J Cancer. 2024;15:2123\u201336.","journal-title":"J Cancer"},{"key":"3331_CR16","first-page":"8597","volume":"234","author":"H Deli","year":"2018","unstructured":"Deli H, Andrew JF, Jonathan AG, Coralee ET, Joseph RB, Kirsten MT, et al. RUNX1-dependent mechanisms in biological control and dysregulation in cancer. J Cell Physiol. 2018;234:8597\u2013609.","journal-title":"J Cell Physiol"},{"key":"3331_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-024-00573-1","volume":"12","author":"X Guo","year":"2024","unstructured":"Guo X, Zhang H, He C, Qin K, Lai Q, Fang Y, et al. RUNX1 promotes angiogenesis in colorectal cancer by regulating the crosstalk between tumor cells and tumor associated macrophages. Biomark Res. 2024;12:29.","journal-title":"Biomark Res"},{"key":"3331_CR18","doi-asserted-by":"publisher","first-page":"8846","DOI":"10.1158\/0008-5472.CAN-04-2066","volume":"64","author":"J Planaguma\u0300","year":"2004","unstructured":"Planaguma\u0300 J, Di\u0301az-Fuertes M, Gil-Moreno A, Abal M, Monge M, Garci\u0301a A, et al. A differential gene expression profile reveals overexpression of RUNX1\/AML1 in invasive endometrioid carcinoma. Cancer Res. 2004;64:8846\u201353.","journal-title":"Cancer Res"},{"key":"3331_CR19","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.7150\/ijbs.47225","volume":"16","author":"T Lina","year":"2020","unstructured":"Lina T, Yunling G, Yongqi S, Yang L, Yanshu L, Hongyan Z, et al. PAK4 phosphorylating RUNX1 promotes ER\u03b1-positive breast cancer-induced osteolytic bone destruction. Int J Biol Sci. 2020;16:2235\u201347.","journal-title":"Int J Biol Sci"},{"key":"3331_CR20","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1158\/0008-5472.CAN-19-3870","volume":"80","author":"R Nicholas","year":"2020","unstructured":"Nicholas R, Susan MM, Laura M, Henry JMD, Kirsteen JC, Ann H, et al. RUNX1 is a driver of renal cell carcinoma correlating with clinical outcome. Cancer Res. 2020;80:2325\u201339.","journal-title":"Cancer Res"},{"key":"3331_CR21","first-page":"e2302203","volume":"11","author":"T Philip Chiu-Tsun","year":"2023","unstructured":"Philip Chiu-Tsun T, Max Kam-Kwan C, Jeff Yat-Fai C, Alex Siu-Wing C, Dongmei Z, Chunjie L, et al. Hematopoietic transcription factor RUNX1 is essential for promoting macrophage-myofibroblast transition in non-small-cell lung carcinoma. Adv Sci. 2023;11:e2302203.","journal-title":"Adv Sci"},{"key":"3331_CR22","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1186\/s13046-019-1330-9","volume":"38","author":"L Qingyuan","year":"2019","unstructured":"Qingyuan L, Qiuhua L, Chengcheng H, Yuxin F, Qun Y, Yue Z, et al. RUNX1 promotes tumour metastasis by activating the Wnt\/\u03b2-catenin signalling pathway and EMT in colorectal cancer. J Exp Clin Cancer Res. 2019;38:334.","journal-title":"J Exp Clin Cancer Res"},{"key":"3331_CR23","doi-asserted-by":"publisher","first-page":"6363","DOI":"10.7150\/jca.51338","volume":"12","author":"L Qingyuan","year":"2021","unstructured":"Qingyuan L, Qiuhua L, Chengcheng H, Haonan Z, Xingzhu P, Haolin L, et al. RUNX1 regulates the proliferation and chemoresistance of colorectal cancer through the Hedgehog signaling pathway. J Cancer. 2021;12:6363\u201371.","journal-title":"J Cancer"},{"key":"3331_CR24","doi-asserted-by":"publisher","first-page":"116307","DOI":"10.1016\/j.bcp.2024.116307","volume":"225","author":"HS Nadin","year":"2024","unstructured":"Nadin HS, Dana MZ, Nour NAJ, Salma HM, Hussein HI, Hany AO. The interplay of p38 MAPK signaling and mitochondrial metabolism, a dynamic target in cancer and pathological contexts. Biochem Pharmacol. 2024;225:116307.","journal-title":"Biochem Pharmacol"},{"key":"3331_CR25","doi-asserted-by":"publisher","first-page":"132686","DOI":"10.1016\/j.ijbiomac.2024.132686","volume":"271","author":"Y Yaping","year":"2024","unstructured":"Yaping Y, Tengkun D, Mengmeng G, Xu Z, Chao C, Ya Z, et al. A review of non-classical MAPK family member, MAPK4: a pivotal player in cancer development and therapeutic intervention. Int J Biol Macromol. 2024;271:132686.","journal-title":"Int J Biol Macromol"},{"key":"3331_CR26","doi-asserted-by":"publisher","first-page":"2648","DOI":"10.1093\/annonc\/mdx401","volume":"28","author":"E Sanz-Garcia","year":"2017","unstructured":"Sanz-Garcia E, Argiles G, Elez E, Tabernero J. BRAF mutant colorectal cancer: prognosis, treatment, and new perspectives. Ann Oncol. 2017;28:2648\u201357.","journal-title":"Ann Oncol"},{"key":"3331_CR27","first-page":"1026","volume":"4","author":"WP Daniel","year":"2005","unstructured":"Daniel WP, Allan SH, Suzie P, Patrick SS. Design and development of polymers for gene delivery. Nat Rev Drug Discov. 2005;4:1026.","journal-title":"Nat Rev Drug Discov"},{"key":"3331_CR28","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1021\/nn504905q","volume":"9","author":"M Antonella","year":"2015","unstructured":"Antonella M, Stephany Yi T, Kristen Lynn K, Yuan W, Yike J, David G, et al. Polymeric nanoparticles for nonviral gene therapy extend brain tumor survival in vivo. ACS Nano. 2015;9:1236\u201349.","journal-title":"ACS Nano"},{"key":"3331_CR29","doi-asserted-by":"publisher","first-page":"e1900772","DOI":"10.1002\/adhm.201900772","volume":"9","author":"Z Lingmin","year":"2020","unstructured":"Lingmin Z, Sai D, Yanfen Z, Qingsheng P, Huan L, Ping W, et al. Homotypic targeting delivery of siRNA with artificial cancer cells. Adv Healthc Mater. 2020;9:e1900772.","journal-title":"Adv Healthc Mater"},{"key":"3331_CR30","doi-asserted-by":"publisher","first-page":"113513","DOI":"10.1016\/j.yexcr.2023.113513","volume":"426","author":"X Zuoming","year":"2023","unstructured":"Zuoming X, Yinghong W, Meng Y, Huamei W, Jian P. CBX2-mediated suppression of SIAH2 triggers WNK1 accumulations to promote glycolysis in hepatocellular carcinoma. Exp Cell Res. 2023;426:113513.","journal-title":"Exp Cell Res"},{"key":"3331_CR31","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1038\/s41419-023-06304-y","volume":"14","author":"Y Xing","year":"2023","unstructured":"Xing Y, Ba-Tu J, Dong C, Cao X, Li B, Jia X, et al. Phosphorylation of USP27X by GSK3\u03b2 maintains the stability and oncogenic functions of CBX2. Cell Death Dis. 2023;14:782.","journal-title":"Cell Death Dis"},{"key":"3331_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41389-018-0103-1","volume":"7","author":"JW Lindsay","year":"2018","unstructured":"Lindsay JW, Zachary LW, Lubna Q, Tomomi MY, Miriam DP, Amber AB, et al. CBX2 identified as driver of anoikis escape and dissemination in high grade serous ovarian cancer. Oncogenesis. 2018;7:92.","journal-title":"Oncogenesis"},{"key":"3331_CR33","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.3390\/cancers14143491","volume":"14","author":"JB Lucie","year":"2022","unstructured":"Lucie JB, Chloe W, Rebecca MH, Shannon K, Ella W, Thomas F, et al. The epigenetic regulatory protein CBX2 promotes mTORC1 signalling and inhibits DREAM complex activity to drive breast cancer cell growth. Cancers. 2022;14:3491.","journal-title":"Cancers"},{"key":"3331_CR34","doi-asserted-by":"publisher","first-page":"110148","DOI":"10.1016\/j.cellsig.2021.110148","volume":"88","author":"X Zhao","year":"2021","unstructured":"Zhao X, Li L, Yuan S, Zhang Q, Jiang X, Luo T. SPIB acts as a tumor suppressor by activating the NFkB and JNK signaling pathways through MAP4K1 in colorectal cancer cells. Cell Signal. 2021;88:110148.","journal-title":"Cell Signal"},{"key":"3331_CR35","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1016\/j.bbamcr.2012.07.004","volume":"1823","author":"Q Wang","year":"2012","unstructured":"Wang Q, Zhang Y, Yang H. Pdcd4 knockdown up-regulates MAP4K1 expression and activation of AP-1 dependent transcription through c-Myc. Biochim Biophys Acta. 2012;1823:1807\u201314.","journal-title":"Biochim Biophys Acta"},{"key":"3331_CR36","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nrd1775","volume":"4","author":"D Pack","year":"2005","unstructured":"Pack D, Hoffman A, Pun S, Stayton P. Design and development of polymers for gene delivery. Nat Rev Drug Discov. 2005;4:581\u201393.","journal-title":"Nat Rev Drug Discov"},{"key":"3331_CR37","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/s41419-018-0359-6","volume":"9","author":"X Liu","year":"2018","unstructured":"Liu X, Li X, Zheng P, Yang W. DAX1 promotes cervical cancer cell growth and tumorigenicity through activation of Wnt\/\u03b2-catenin pathway via GSK3\u03b2. Cell Death Dis. 2018;9:339.","journal-title":"Cell Death Dis"},{"key":"3331_CR38","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/s41417-024-00743-1","volume":"31","author":"B Wang","year":"2024","unstructured":"Wang B, Zhang S, Wang H, Wang M, Tao Y, Ye M, et al. Identification of EGR4 as a prospective target for inhibiting tumor cell proliferation and a novel biomarker in colorectal cancer. Cancer Gene Ther. 2024;31:871\u201383.","journal-title":"Cancer Gene Ther"},{"key":"3331_CR39","doi-asserted-by":"crossref","unstructured":"Zhongguang L, Bangting W, Feifei L, Yumeng G, Ning J, Jinsong W, et al. Establishment of a large-scale patient-derived high-risk colorectal adenoma organoid biobank for high-throughput and high-content drug screening. BMC Med. 2023;21:336.","DOI":"10.1186\/s12916-023-03034-y"}],"updated-by":[{"DOI":"10.1038\/s41388-026-03677-0","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000}}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03331-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03331-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03331-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T06:41:45Z","timestamp":1769064105000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03331-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,13]]},"references-count":39,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2025,4,14]]}},"alternative-id":["3331"],"URL":"https:\/\/doi.org\/10.1038\/s41388-025-03331-1","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,13]]},"assertion":[{"value":"25 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: In the original version of Fig.2F, the \u201cOE-control group\u201d data for the HT29 cell line were inadvertently used. This panel has been replaced with the correct data. The authors confirm that this correction does not alter the reported results or conclusions of the manuscript. The authors agree to the modification and sincerely apologize for any inconvenience caused.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":9,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":10,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41388-026-03677-0","URL":"https:\/\/doi.org\/10.1038\/s41388-026-03677-0","order":12,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The human study was approved by the Ethical Committee of Medical Research, The First Affiliated Hospital with Nanjing Medical University, and informed consent was obtained from all participants (2018-SR-258). All animal experimental protocols were approved by the Ethical Committee of Medical Research, Nanjing Medical University (IACUC-2207042). No blinding was done to both human and animal studies. The sample sizes for animal studies are three to six for each independent experiments as described in the relevant figure legends.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}